Temasek and DCVC lead Pivot Bio’s US$430M series D funding round

Iowa farmer using Pivot Bio product. Credit: Pivot BioIowa farmer using Pivot Bio product. Credit: Pivot Bio

Microbial nitrogen fertilizer company Pivot Bio closed a US$430 million series D funding round led by DCVC and Singapore’s state-owned investment company Temasek, the company said in a press release Monday.

The round brought the total raised by Pivot Bio to more than US$600 million, the statement said.

New investors in the round included Generation Investment Management, G2 Venture Partners and Rockefeller Capital Management, while returning investors including Breakthrough Energy Ventures, Continental Grain Co., Prelude Ventures, Temasek subsidiary Pavilion Capital, Bunge Ventures, Tekfen Ventures and Biotech company Becker Underwood co-founder Roger Underwood, the statement said.

“Pivot Bio exemplifies the power of DeepTech solutions to create equitable and profitable outcomes for all stakeholders in immense industries like agriculture,” said Matt Ocko, co-managing partner of DCVC, in the statement. “Farmers are able to grow more crops to feed more people, more cost-effectively, while being even better stewards of their land and water. Societies benefit from both more abundant food and more climate-resilient and sustainable agriculture. Pivot Bio has delivered the kind of win-win-win breakthrough DCVC is honored to back, and on which we are focused as a firm.”

The funding is earmarked to accelerate the release of the company’s products, which aim to replace synthetic nitrogen fertilizer as that contributes around 7 percent of global greenhouse gas emissions, depletes soils and harms water supplies and fisheries, Pivot Bio said.

The company said it has replaced synthetic nitrogen on more than a million crop acres this year alone, for more than 300 percent on-year growth.

Pivot Bio PROVEN 40, the company’s fourth commercial product in three years, lets farmers replace up to 40 pounds per acre of synthetic nitrogen, nearly double the first product, and it eliminates the machinery and labor needed for synthetic nitrogen, the statement said.

In April 2020 Pivot Bio raised a US$100 million series C round led by Breakthrough Energy Ventures and Temasek, and in October 2018, it raised a US$70 million series B round led by Breakthrough Energy Ventures, according to data from Crunchbase.

In 2016, the company had a US$16 million series A round led by DCVC, and in 2014, it had a seed round that riased US$750,000 led by DCVC and Monsanto Growth Ventures, the data show.